Evidence map›Paper›PMID 35753763›Full record

Observational studyNeurologia medico-chirurgica2022

Impact of COVID-19 on the Volume of Acute Stroke Admissions: A Nationwide Survey in Japan.

Takeshi Yoshimoto, Hiroshi Yamagami, Nobuyuki Sakai, Kazunori Toyoda, Yoichiro Hashimoto, Teruyuki Hirano, Toru Iwama, Rei Goto, Kazumi Kimura, Satoshi Kuroda and 12 more

Abstract readObservational Study
In one paragraph

Observational study in Neurologia medico-chirurgica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Takeshi YoshimotoDepartment of Neurology, National Cerebral and Cardiovascular Center.
Hiroshi YamagamiDepartment of Stroke Neurology, National Hospital Organization Osaka National Hospital.
Nobuyuki SakaiDepartment of Neurosurgery, Kobe City Medical Center General Hospital.
Kazunori ToyodaDepartment of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center.
Yoichiro HashimotoDepartment of Neurology, Kumamoto City Hospital.
Teruyuki HiranoDepartment of Stroke and Cerebrovascular Medicine, Kyorin University.
Toru IwamaDepartment of Neurosurgery, Gifu University Graduate School of Medicine.
Rei GotoGraduate School of Business Administration, Keio University.
Kazumi KimuraDepartment of Neurology, Nippon Medical School Hospital.
Satoshi KurodaDepartment of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama.
Yuji MatsumaruDepartment of Neurosurgery, Tsukuba University.
Susumu MiyamotoDepartment of Neurosurgery, Kyoto University.
Kuniaki OgasawaraDepartment of Neurosurgery, Iwate Medical University.
Yasushi OkadaDepartments of Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Center.
Yoshiaki ShiokawaDepartment of Neurosurgery, Kyorin University.
Yasushi TakagiDepartment of Neurosurgery, Tokushima University Graduate School of Medicine.
Teiji TominagaDepartment of Neurosurgery, Tohoku University Graduate School of Medicine.
Masaaki UnoDepartment of Neurosurgery, Kawasaki Medical School.
Shinichi YoshimuraDepartment of Neurosurgery, Hyogo College of Medicine.
Nobuyuki OharaDepartment of Neurology, Kobe City Medical Center General Hospital.
Hirotoshi ImamuraDepartment of Neurosurgery, Kobe City Medical Center General Hospital.
Chiaki SakaiDepartment of Neurosurgery, Kobe City Medical Center General Hospital.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to measure the impact of the COVID-19 pandemic on the volumes of annual stroke admissions compared with those before the pandemic in Japan. We conducted an observational, retrospective nationwide survey across 542 primary stroke centers in Japan. The annual admission volumes for acute stroke within 7 days from onset between 2019 as the pre-pandemic period and 2020 as the pandemic period were compared as a whole and separately by months during which the epidemic was serious and prefectures of high numbers of infected persons. The number of stroke patients declined from 182,660 in 2019 to 178,083 in 2020, with a reduction rate of 2.51% (95% confidence interval [CI], 2.58%-2.44%). The reduction rates were 1.92% (95% CI, 1.85%-2.00%; 127,979-125,522) for ischemic stroke, 3.88% (95% CI, 3.70%-4.07%, 41,906-40,278) for intracerebral hemorrhage, and 4.58% (95% CI, 4.23%-4.95%; 13,020-12,424) for subarachnoid hemorrhage. The admission volume declined by 5.60% (95% CI, 5.46%-5.74%) during the 7 months of 2020 when the epidemic was serious, whereas it increased in the remaining 5 months (2.01%; 95% CI, 1.91%-2.11%). The annual decline in the admission volume was predominant in the five prefectures with the largest numbers of infected people per million population (4.72%; 95% CI, 4.53%-4.92%). In conclusion, the acute stroke admission volume declined by 2.51% in 2020 relative to 2019 in Japan, especially during the months of high infection, and in highly infected prefectures. Overwhelmed healthcare systems and infection control practices may have been associated with the decline in the stroke admission volume during the COVID-19 pandemic.

Indexed as

COVID-19StrokeHumansJapanPandemicsRetrospective Studiesadmissioncoronavirus disease-2019Japannationwide surveystroke

Identifiers

PMID35753763
PMCPMC9464481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.